This ETF's Trouncing the S&P 500 by 10 Percentage Points in 2026, and It Can Keep Outperforming

The Schwab U.S. Dividend Equity ETF (SCHD) is up 14.1% year to date, well ahead of the S&P 500's 4.2% total return and Vanguard Value ETF's 7.5% gain. The article argues that SCHD's quality-screened, dividend-growth approach—backed by a 0.06% expense ratio—positions it to benefit from AI infrastructure spending, lower rates, pro-business tax policy, and elevated value-stock valuations versus growth stocks. This is constructive commentary rather than new fund-specific news, so market impact should be limited.

Analysis

The real trade here is not “dividend ETF versus growth,” but a crowded-capital reallocation from balance-sheet-light software into cash-generative industrial, energy, and healthcare franchises. If AI capex stays elevated, the second-order winners are the picks-and-shovels names exposed to data-center buildout, grid upgrades, and heavy equipment refresh cycles; that matters more than the headline AI winners because spend is still flowing even as sentiment wobbles. The ETF’s construction also creates a quality screen that naturally reduces exposure to duration-sensitive, low-free-cash-flow businesses, which should matter if rates stay only modestly lower rather than collapsing.

The key risk is that the market is already partially “in” this rotation: if the macro backdrop softens, defensive yield names can become value traps rather than compounders. Higher-tax-refund support to staples is likely a second-half story, not an immediate catalyst, while lower rates help financials only if credit remains benign and deal activity re-accelerates. The biggest reversal risk is a broad earnings downgrade cycle in industrials/energy that would compress dividend-growth premium multiples faster than the ETF’s income stream can compensate.

The valuation spread between quality value and growth still leaves room for continuation, but I’d frame this as a months-long factor trade rather than a one-week momentum chase. What consensus may be missing is that the “AI beneficiaries” on the supply side can sustain outperformance even if AI software multiples keep derating, because capex commitments are contractual and slow to unwind. That argues for owning cash flow visibility over narrative exposure until we see evidence of a capex slowdown or a sharp reset in power/industrial order books.

Key Decisions for Investors

• Initiate a 3-6 month long SCHD / short QQQ pair: the cleaner quality-cash-flow basket should outperform if AI multiples keep compressing while capex spend remains intact; target 5-8% relative alpha, stop if growth leadership reasserts and QQQ outperforms by >7% over 6-8 weeks.
• Overweight CVX and COP versus integrated industrial proxies with weaker free-cash-flow conversion; the setup favors dividend-capable energy names if AI/data-center power demand keeps industrial utilization high. Use a 2-4 month horizon and trim if crude weakens materially or refining margins roll over.
• Add TXN on a 6-12 month basis as a quality cyclically leveraged beneficiary of industrial and equipment spend; risk/reward improves on any 5-10% pullback because the market is paying for resilience, not peak growth.
• Use UNH and AMGN as defensive healthcare longs versus high-multiple software exposure; if the market rotates further into quality, these can work even in a flat tape. Exit if regulatory headlines or reimbursement pressure tighten materially.
• Fade VZ as a pure yield substitute unless rates fall sharply; the balance-sheet and growth profile make it a lower-quality leg inside the income universe, so it is best expressed as a relative short versus SCHD or versus higher-quality telecom-free cash flow names.